CAS: 15051-81-7; 2-((2R,4As)-4A,8-Dimethyl-1,2,3,4,4A,5,6,7-Octahydronaphthalen-2-yl)Propan-2-Ol

该化合物是一种属于eudesmane家族的精液酒精,因其结构稳定性得到承认,在香味和口味配方中具有多种用途.它的木质和琥珀状芳香使它成为香水中的宝贵成分,有助于复杂的气味特征.该化合物具有显著的热和氧化稳定性,确保最终产品的寿命.此外,上-欧洲单体摩尔还研究其潜在的生物活性特性,包括温和的反炎效应,扩大其在制药和化妆品研究中的关联性.它自然出现在基本油类中,如雪茄和雪茄,强调其与可持续来源做法的兼容性.该化合物的纯性和一致性对于工业应用中的再生性能至关重要.

结构式图片

欧盟法规

C&L通报

上下游产品

Epi-Carrisone 7-epi-cyperone 2-((3E,8E)-4,8-Dimethyl-cyclodeca-3,8-dienyl)-propan-2-ol 4-epi-trans-dihydroagarofuran 4,9]dodecane(1R,4S,8S,9R)-2,2,4,8-Tetramethyl-3-oxa-tricyclo[6.2.2.04,9]dodecane

合成工艺路线路线简述

    📜7-Epi-Cyperone置于lithium Aluminium Tetrahydride,Dichloroalane,间氯过氧苯甲酸体系中,用 乙醚,二氯甲烷 用作溶剂,化学反应 22.0H,反应生成表桉叶油醇
    参考文献:An Efficient Stereocontrolled Synthesis Of (−)-10-Epi-5β,11-Dihydroxyeudesmane And (−)-4,10-Epi-5β,11-Dihydroxyeudesmane
    标题:An Efficient Stereocontrolled Synthesis Of (−)-10-Epi-5β,11-Dihydroxyeudesmane And (−)-4,10-Epi-5β,11-Dihydroxyeudesmane
    摘要:A Concise And Efficient Synthesis Of (-)-10-Epi-5 Beta,11-Dihydroxyeudesmane 1 And (-)-4,10-Epi-5 Beta,11-Dihydroxyeudesmane 2,Via (-)-10-Epi-Gamma-Eudesmol 5,Was Accomplished Starting From (+)-Dihydrocarvone. The Salient Feature Of Our Synthesis Is The Utilization Of Substrate-Directable Epoxidation And Homogeneous Hydrogenation To Control The Stereochemistry At The C-4 And C-5 Positions Of The Title Compounds. (C) 1998 Published By Elsevier Science Ltd. All Rights Reserved.
    Doi:10.1016/s0957-4166(98)00141-4

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1080/10412905.2000.9699486
    摘要:Paniandy J-, Chane-Ming J, Pieribattesti J-. Chemical Composition of the Essential Oil and Headspace Solid-Phase Microextraction of the Guava Fruit (Psidium guajava L.). Journal of Essential Oil Research. 2000 Mar;12(2):153–8. doi: 10.1080/10412905.2000.9699486.
    参考文献:10.1076/phbi.35.3.218.13295
    摘要:Souleles C, Argyriadou N. Constituents of the Essential Oil of Salvia sclarea Growing Wild in Greece. International Journal of Pharmacognosy. 1997 Jan;35(3):218–20. doi: 10.1076/phbi.35.3.218.13295.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知